Can discussion of health inequities lead to actionable change?

by Marci A. Landsmann

From the Editor-in-Chief

Research is leading to treatments that target cancer's support system.

by William G. Nelson, MD, PhD 

Forward Look

Cellular immunotherapies can offer periods when people do not require treatment.

by Christina Bennett

Forward Look

Most people who opt out of breast reconstruction are satisfied with their decision but are not always supported by their surgeons.

by Kris Conner

A study compares the benefits of fixed doses of immunotherapy compared to weight-based doses, and the Food and Drug Administration approves a targeted therapy for a rare disorder called systemic mastocytosis.

by Bradley Jones

Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.

by Laurie Adami

Testing for hereditary mutations is increasingly recommended for people with cancer, but recommendations do not always translate into access to testing and appropriate counseling.

by Kate Yandell

At a patient advocate event, researchers discussed how to extend the benefits of immunotherapy to more people.

by Kevin McLaughlin

Testing children with cancer for hereditary mutations could impact their treatment and provide information relevant to other family members.

by Marcus A. Banks

Researchers are investigating who is at greatest risk for radiation-induced cancers.

by Kate Yandell